Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus atracurium for tracheal intubation conditions in children under propofol-sufentanil anesthesia
IRCT20201028049177N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine, atracurium, propofol and sufentanil (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Success rate in intubation. Started Mar 2019; status: completed.
02
Drugs
dexmedetomidineatracuriumpropofolsufentanil
Beyond the preview
Go deeper on IRCT20201028049177N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201028049177N1.